ArticleFrontiers in oncology2023

Cerebrospinal fluid ctDNA testing shows an advantage over plasma ctDNA testing in advanced non-small cell lung cancer patients with brain metastases.

Xiaocui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.